Drugs
FDA clears Inqovi plus venetoclax for newly diagnosed AML
The FDA approved the first fully oral frontline regimen for certain adults with newly diagnosed AML.
Drugs & therapeutics
Drug approvals, compounding updates, shortages, formulary changes, biologics.
131 stories
Drugs
Revvity adds FDA-cleared total testosterone assay to ChLIA menu
FDA clearance gives Revvity a full automated testosterone-testing portfolio on one IDS platform.
Drugs
EU expands Hympavzi approval to hemophilia patients with inhibitors
Pfizer won EC approval to expand Hympavzi’s EU label to hemophilia A and B patients with inhibitors.
Drugs
Reusable 3D-printing ink shows promise for gabapentin tablets
A new study suggests some gelatin-based inks can be reused to 3D print personalized veterinary gabapentin tablets.
Drugs
Protecting kidney function during anesthesia stays in focus
A veterinary anesthesia update underscores individualized planning, monitoring, and fluid therapy for dogs and cats with renal disease.
Drugs
Boehringer adds recheck option to equine PPID testing program
Boehringer expanded its IDPPID program so vets can recheck newly treated PPID horses during the 2026 testing windows.
Drugs
FDA expands Bizengri to NRG1 fusion-positive cholangiocarcinoma
Bizengri won FDA approval for previously treated NRG1 fusion-positive cholangiocarcinoma, its third US indication.
Drugs
EU expands Sotyktu label to adults with active psoriatic arthritis
The European Commission approved BMS’ Sotyktu for adults with active psoriatic arthritis after prior DMARD failure or intolerance.
Drugs
FDA expands Vyvgart label to all adults with generalized MG
argenx said the FDA broadened Vyvgart and Vyvgart Hytrulo to all adult patients with generalized myasthenia gravis.
Drugs
GSK taps Sino Biopharm unit to speed bepirovirsen launch in China
GSK has partnered with Sino Biopharmaceutical’s CTTQ to accelerate a China launch for bepirovirsen in chronic hepatitis B.
Drugs
Henlius advances cetuximab biosimilar toward the U.S. market
Henlius says HLX05-N, a biosimilar to Erbitux, has cleared an FDA IND step as it prepares an international phase 1 study.
Drugs
Zoetis adds CHCM and PCT to Vetscan OptiCell
Zoetis expanded Vetscan OptiCell with CHCM and plateletcrit, adding two deeper CBC parameters to its in-clinic hematology menu.
Drugs
FDA approves first dual-indication anxiety drug for dogs
Tessie is the first FDA-approved drug for both noise aversion and separation anxiety in dogs.
Drugs
Study finds menbutone boosts albendazole exposure in calves
A Frontiers study found menbutone increased albendazole sulfoxide exposure in calves by about 30%, though a second dose added no benefit.
Drugs
Study examines extended-release buprenorphine in Amazon parrots
New AJVR research adds pharmacokinetic and body temperature data for extended-release lipid buprenorphine in Hispaniolan Amazon parrots.
Drugs
GSK licenses Siran Bio’s SA030 in deal worth up to $1B
GSK paid $55 million upfront for ex-China rights to Siran Bio’s Phase 1 siRNA metabolic therapy SA030.
Drugs
Bimeda launches first FDA-approved generic omeprazole for horses
Bimeda’s Gastrobim is now available in the U.S. as the first FDA-approved bioequivalent to GastroGard for equine gastric ulcers.
Drugs
FDA clears Tessie for noise aversion and separation anxiety in dogs
Tessie is the first FDA-approved single drug for both noise aversion and separation anxiety in dogs.
Drugs
FDA clears Langlara, a new interchangeable Lantus biosimilar
Lannett and Sunshine Lake Pharma won FDA approval for Langlara, an interchangeable biosimilar to Lantus.
Drugs
Topical beta-blocker may offer new option for feline angiomatosis
A Veterinary Dermatology case report describes successful topical beta-blocker treatment of a painful metatarsal pad angiomatosis lesion in a cat.
Drugs
Dexmedetomidine shows anaesthetic benefits in endotoxaemic horses
A new equine study found dexmedetomidine improved cardiac index and renal markers during anaesthesia after endotoxaemia.
Drugs
EC expands Imcivree approval to acquired hypothalamic obesity
Rhythm’s Imcivree won EU authorization for acquired hypothalamic obesity, extending MC4R-targeted treatment into a new rare-disease setting.
Drugs
Tea saponin shows narrow dosing window in hybrid grouper study
A new study suggests tea saponin can help or harm hybrid grouper liver health, depending on dose.
Drugs
FDA clears feline amlodipine as BOAS injectable draws attention
FDA approved the first veterinary amlodipine for cats, while early BOAS and feline cancer studies point to future shifts in care.
Drugs
FDA expands Auvelity use to Alzheimer’s-related agitation
Axsome’s Auvelity won FDA approval as the first non-antipsychotic option for agitation tied to Alzheimer’s dementia.
Drugs
ProHeart 12 keeps the focus on year-long heartworm compliance
Sponsored coverage spotlights ProHeart 12’s once-yearly dosing, but the bigger issue for clinics is heartworm prevention compliance.
Drugs
Study gives first PK data for ertugliflozin in horses
A new equine study suggests enteral ertugliflozin is rapidly absorbed and may support once-daily dosing.
Drugs
Theradaptive moves OsteoAdapt SP into pivotal FDA-backed trial
Theradaptive won FDA clearance to start a pivotal Phase 3 study of OsteoAdapt SP in spinal fusion.
Drugs
FDA approves first veterinary amlodipine drug for feline hypertension
FDA has approved Amodip, the first veterinary amlodipine product for cats with systemic hypertension.
Drugs
Synthetic cannabinoids test the limits of equine doping control
A new review outlines why synthetic cannabinoids are unusually difficult to detect in racehorses.
Drugs
FDA approves first generic moxidectin drench for sheep
First Priority’s OTC generic moxidectin drench for sheep is now FDA-approved as a bioequivalent to Cydectin.
Drugs
FDA grants priority review to Tevimbra combo in HER2+ GEA
BeOne’s Tevimbra combination won FDA Priority Review after phase 3 data showed a survival gain in first-line HER2-positive GEA.
Drugs
FDA approves first veterinary amlodipine for feline hypertension
FDA cleared Amodip, the first veterinary amlodipine product for cats with systemic hypertension.
Drugs
HUTCHMED wins priority review in China for sovleplenib in wAIHA
China’s NMPA accepted HUTCHMED’s sovleplenib filing for wAIHA and granted priority review.
Drugs
Study adds clinical evidence for lipid emulsion in pet neurotoxicosis
A new case series links stronger xenobiotic lipid partitioning during ILE to early neurologic improvement in dogs and cats.
Drugs
Turmeric extract clears a feline safety test in new study
A four-month study found turmeric extract was well tolerated in healthy adult cats at tested dietary levels.
Drugs
FDA expands Vetmedin’s role in preclinical canine heart disease
Vetmedin tablets and solution are now FDA-approved to delay CHF onset in dogs with Stage B2 preclinical MMVD.
Drugs
Study adds context to flea- and tick-related disease risk in cats
New research on Cytauxzoon felis highlights why prevention and smarter diagnostics matter in feline practice.
Drugs
FDA grants EUA to F10 spray for New World screwworm
FDA authorized F10 wound spray for New World screwworm prevention and treatment in multiple animal species.
Drugs
Large feline case series adds data on off-label oclacitinib use
A 238-cat case series found off-label oclacitinib controlled skin disease signs in 59% of cats, with mostly mild adverse events.
Drugs
Evidence reshapes antibiotic use for canine acute diarrhea
New guidance says most dogs with acute diarrhea don't need antibiotics, even in many hemorrhagic cases.
Drugs
Study supports more selective antibiotic use in foal pneumonia
A new study found conservative antimicrobial use in foal bronchopneumonia cut treatment rates without worsening outcomes.
Drugs
Why veterinary prescribing still feels harder than it should
Instinct says fragmented prescribing workflows raise cognitive load, error risk, and staff burden in veterinary practice.
Drugs
FDA grants EUA for F10 topical spray against New World screwworm
FDA authorized F10 wound spray for New World screwworm in multiple animal species, expanding topical treatment options under emergency use.
Drugs
FDA clears Regeneron gene therapy for OTOF-related hearing loss
Regeneron’s Otarmeni became the first approved gene therapy for a genetic form of hearing loss.
Drugs
DemeRx wins FDA IND acceptance for DMX-1001 in AUD
FDA accepted DemeRx’s IND for DMX-1001 in alcohol use disorder, setting up an alcohol interaction study and a possible Phase 2 start in 2027.
Drugs
FDA approves Merck’s Idvynso for suppressed HIV-1 adults
Merck’s new once-daily, two-drug HIV tablet won FDA approval for adults switching from a stable suppressive regimen.
Drugs
FDA expands Tzield use to children as young as 1
Sanofi said the FDA expanded Tzield’s label to children age 1 and older with stage 2 type 1 diabetes.
Drugs
Genentech posts Phase III win for Enspryng in MOGAD
Phase III data show satralizumab cut relapse risk by 68% in MOGAD, with filings planned.
Drugs
Regeneron advances cemdisiran after Phase 3 gMG data
Regeneron reported detailed Phase 3 NIMBLE results and said it has submitted a U.S. application for cemdisiran in gMG.
Drugs
Study links stubborn canine yeast otitis to miconazole resistance
University of Illinois researchers identified ERG11-linked reduced miconazole susceptibility in Malassezia from dogs with otitis externa.
Drugs
Home laser rentals gain traction for senior pet care compliance
Veterinary leaders say home laser rentals may help senior pets stay on photobiomodulation treatment plans.
Drugs
At-home laser therapy gains traction as compliance tool
Veterinary groups are revisiting home laser programs as a way to improve adherence for geriatric and chronic-care patients.
Drugs
Flea and tick disease risk in cats keeps prevention in focus
Newer education efforts stress that fleas and ticks pose meaningful health risks to cats, including many that live indoors.
Drugs
Trojan horse antibiotic strategies gain attention in Pseudomonas
A new review highlights siderophore-linked antibiotics as a possible path around Pseudomonas aeruginosa resistance.
Drugs
Review finds limited but positive evidence for grapiprant in dogs
A new review says grapiprant may help chronic canine osteoarthritis pain, but the overall evidence remains weak.
Drugs
ABCD updates FIP treatment guidance as antiviral use expands
New ABCD guidance says FIP is now often treatable and curable when antivirals are available.
Drugs
Why swimming and bathing advice matters for dog spot-on parasite meds
Topical canine antiparasitics don’t all handle bathing or swimming the same way, and labels matter.
Drugs
FIP antiviral success brings a new stewardship challenge
Experts say cats need continued access to FIP antivirals, but careless use could raise resistance risks.
Drugs
Equine wound care update highlights stage-based topical choices
New equine wound education emphasizes matching topical therapy to wound type, location, and healing stage.
Drugs
Generic omeprazole adds a new option for equine gastric disease
FDA’s first generic omeprazole paste could improve access, but diagnosis and disease subtype still drive treatment.
Drugs
Naloxone training gains relevance as opioid overdoses threaten dogs
Veterinary guidance is reinforcing that naloxone can reverse opioid overdose in dogs, but follow-up emergency care is still essential.
Drugs
Veterinary Apothecary highlights new dermatology drug, safety signals
A dvm360 roundup spotlights new veterinary drug approvals, with Zenrelia’s vaccine warning drawing particular clinical attention.
Drugs
Pregabalin linked to slower MRI anaesthetic recovery in horses
A new equine study found pregabalin prolonged time to standing after isoflurane anaesthesia, without worsening recovery quality.
Drugs
What in-house vaccine titering could mean for practice
Point-of-care vaccine titers are gaining attention as a tool for more individualized vaccination decisions in dogs and cats.
Drugs
Do split vaccine visits help reduce reactions in small dogs?
Experts say spacing vaccines may help some small dogs, but reducing the dose itself isn’t recommended.
Drugs
Equine gastric disease treatment focus shifts to tailored care
New coverage highlights that equine gastric disease treatment depends on lesion type, confirmed diagnosis, and management change.
Drugs
Splitting vaccines in small dogs may not lower reaction risk
Experts say spacing vaccines may help some small dogs, but reducing dose volume isn’t supported by evidence.
Drugs
PetMD update reinforces rabbit-safe flea treatment guidance
A new PetMD explainer reminds clinicians and pet parents that flea control in rabbits requires species-specific treatment.
Drugs
FDA approval puts Numelvi into the canine itch market
Merck’s new oral JAK inhibitor gives veterinarians another option for managing allergic itch in dogs.
Drugs
FDA clears Numelvi, adding a new JAK option for itchy dogs
Merck’s Numelvi gives veterinarians a new oral option for canine allergic dermatitis, with a label that starts at 6 months.
Drugs
Andy Roark episode spotlights quick sedation for dogs and cats
A new HDYTT episode focuses on reversible sedation, analgesia, and local blocks for short canine and feline procedures.
Drugs
Quick sedation protocols move into the clinical spotlight
A new veterinary podcast episode highlights reversible sedation and local blocks for short procedures in dogs and cats.
Drugs
Pre-visit sedation gains ground for fearful dogs and cats
Evidence continues to support quick, targeted sedation before stressful veterinary visits in dogs and cats.
Drugs
Quick sedation gains ground as a workflow tool in vet care
Veterinary guidance increasingly supports early, tailored sedation for fearful or fractious dogs and cats.
Drugs
New VEEV vaccine designs aim to fix old safety tradeoffs
A new review says engineered live-attenuated VEEV vaccines may improve safety, stability, and protection.
Drugs
New VEEV vaccine designs revive interest in safer protection
A new review highlights live-attenuated VEEV vaccine candidates with stronger safety and protection data than TC-83.
Drugs
New review highlights next-gen VEEV vaccines with stronger safety aims
A new review says rationally engineered live-attenuated VEEV vaccines may improve protection while addressing older safety concerns.
Drugs
New VEEV vaccine review spotlights safer live-attenuated options
A new review says complete VEEV protection will likely require both antibody and T-cell responses.
Drugs
Next-generation VEEV vaccines show progress toward full protection
A new review says redesigned live-attenuated VEEV vaccines may improve safety and complete protective immunity.
Drugs
New VEEV vaccine designs draw attention in latest review
A new review says rationally engineered live-attenuated VEEV vaccines may improve safety and protection.
Drugs
New VEEV vaccine designs sharpen equine outbreak preparedness
A new review says next-generation live-attenuated VEEV vaccines may overcome key safety and efficacy limits.
Drugs
New VEEV vaccine review sharpens focus on next-gen protection
A new review says next-generation live-attenuated VEEV vaccines may improve safety, stability, and protective immunity.
Drugs
Equine pain management shifts toward structured assessment
Equine pain guidance is emphasizing earlier assessment, multimodal analgesia, and closer monitoring.
Drugs
Dual antithrombotic therapy gains attention in high-risk cats
A VETgirl podcast highlights evidence that clopidogrel plus rivaroxaban may be tolerated in cats at high thromboembolic risk.
Drugs
Veterinary pharmacy moves closer to specialty recognition
A new petition could create board certification for pharmacists focused on animal health.
Drugs
New study expands antithrombotic options after feline ATE
SUPERCAT found rivaroxaban and clopidogrel had similar outcomes after cardiogenic ATE in cats.
Drugs
Review outlines anaesthetic planning for dogs with MMVD
A new review proposes a stage-based approach to anaesthetic risk in dogs with myxomatous mitral valve disease.
Drugs
FDA expands Bravecto Quantum tick label for dogs
Merck’s Bravecto Quantum now has FDA approval for 12-month control of Asian longhorned and Gulf Coast ticks in dogs.
Drugs
Study adds evidence for more targeted BRD antibiotic use
New cattle transcriptomics research could help veterinarians move from blanket metaphylaxis to more targeted BRD treatment.
Drugs
Study advances case for targeted BRD metaphylaxis in cattle
New transcriptomic research could help veterinarians identify which high-risk cattle truly need BRD metaphylaxis.
Drugs
FDA expands screwworm emergency toolkit with topical spray EUA
FDA authorized F10 topical spray for New World screwworm prevention and treatment in multiple species, with key species and food-safety limits.
Drugs
Veterinary anesthesia teleconsulting gains visibility
A dvm360 podcast spotlights Safe Pet Anesthesia’s real-time teleconsulting model for veterinary teams.
Drugs
Equine gastric disease care shifts toward lesion-specific treatment
New coverage and recent studies reinforce that equine gastric disease treatment depends on diagnosis, lesion type, and management change.
Drugs
ENOVAT review questions routine antibiotics in companion animal surgery
A new ENOVAT evidence review found only small benefit from surgical antimicrobial prophylaxis in dogs and cats.
Drugs
Study highlights rapid response with novel veterinary snake antivenom
A new study found a novel equine F(ab')2 antivenom rapidly reduced venom and improved severity scores in dogs, cats, and horses.
Drugs
Study reports rapid venom clearance with equine F(ab')2 antivenom
A retrospective multicenter study found rapid serum venom removal and improving severity scores after equine F(ab')2 antivenom.
Drugs
FDA approves Numelvi for itch associated with allergic dermatitis
Merck’s once-daily JAK inhibitor is now approved for dogs 6 months and older with pruritus linked to allergic dermatitis.
Drugs
Sedation gains ground as a stress-reduction tool in vet care
A new client-facing explainer underscores how sedation can improve safety, comfort, and care quality for pets, pet parents, and veterinary teams.
Drugs
New evidence sharpens the outlook for ocular FIP treatment
A new case series suggests remdesivir and GS-441524 can improve ocular FIP in most treated cats.
Drugs
Study offers clearer guidance on treating ocular FIP
A new JVIM case series suggests most cats with ocular FIP uveitis can respond well to antiviral therapy.
Drugs
Managed access opens overseas cancer therapy for U.S. dog case
VMD Sciences says it helped a U.S. oncologist import an EU-approved TKI for a dog with metastatic mast cell cancer.
Drugs
Equine wound care review sharpens focus on topical therapy choices
New education and published guidance underscore that topical therapies in horses work best when matched to wound stage and sound wound management.
Drugs
Review finds mixed evidence on propofol speed and apnea in dogs
A new review suggests slower propofol titration may reduce apnea risk mainly by lowering total dose in dogs.
Drugs
Apomorphine and ropinirole data sharpen emetic choice in dogs
New studies suggest both emetics work, but speed, adverse effects, and setting may shape which drug fits best.
Drugs
Apomorphine vs. ropinirole: What the newer canine emesis data show
Newer studies suggest apomorphine may act faster than ropinirole, despite similar overall emetic efficacy in dogs.
Drugs
Clinician’s Brief podcast revisits OA pain management beyond NSAIDs
A new Clinician’s Brief podcast with Robin Downing highlights multimodal osteoarthritis pain management for companion animals.
Drugs
Dr. Robin Downing podcast highlights practical OA pain management
Clinician’s Brief revisits osteoarthritis pain control as vets balance multimodal care, newer biologics, and closer safety monitoring.
Drugs
Dr. Robin Downing spotlights OA pain care beyond NSAIDs
A new Clinician’s Brief podcast highlights practical, multimodal strategies for managing osteoarthritis pain in small animal patients.
Drugs
Apomorphine still leads on speed as ropinirole finds its place
Newer data suggest ropinirole works in dogs, but apomorphine may still be the faster, more reliable emetic in emergency cases.
Drugs
Parvo monoclonal antibody gains ground as treatment and prevention tool
Elanco’s Trutect gives veterinarians a targeted parvo option, with full USDA approval and an added prevention label.
Drugs
Trutect gives veterinarians a targeted option for canine parvo
Elanco’s Trutect now has full USDA approval, adding momentum to targeted treatment and prevention strategies for canine parvovirus.
Drugs
Trutect gains full USDA approval for canine parvovirus
Elanco’s parvo monoclonal antibody now has full USDA approval, expanding a targeted option for treatment and post-exposure use.
Drugs
Targeted parvo therapy gains traction as Trutect enters practice
Elanco’s parvo monoclonal antibody is reshaping care discussions with strong early survival and workflow signals.
Drugs
Trutect’s full USDA approval sharpens parvo treatment options
Elanco’s canine parvovirus monoclonal antibody now has full USDA approval, with implications for treatment protocols and isolation time.
Drugs
Trutect brings targeted therapy to canine parvovirus care
Elanco’s Trutect is now fully USDA approved, giving veterinarians a targeted option for treating canine parvovirus.
Drugs
Ocular FIP treatment enters a more evidence-based era
New discussion around ocular FIP highlights higher-dose antiviral strategies, legal U.S. access, and the need for close follow-up.
Drugs
Why emodepside formulation matters in resistant hookworm care
A new AJVR study found feline and canine emodepside formulations are not bioequivalent in dogs.
Drugs
Study finds emodepside formulations in dogs are not bioequivalent
A new study suggests veterinarians shouldn't treat feline topical and canine oral emodepside as interchangeable in dogs.
Drugs
Study warns emodepside formulation changes exposure in dogs
A new AJVR study found feline topical emodepside is not bioequivalent to a canine oral tablet in dogs.
Drugs
Noninvasive pain therapies gain attention in chronic care
A dvm360 podcast spotlights shock wave and PEMF options as multimodal pain care keeps expanding in veterinary medicine.
Drugs
Why Fear Free care starts before the exam room
A VETgirl podcast argues that sedation and pre-visit meds are part of compassionate care, not a clinical failure.
Drugs
RECOVER’s 2024 CPR updates reshape small animal code response
New RECOVER guidance updates CPR technique, monitoring, and drug use for dogs and cats.
Drugs
Updated RECOVER CPR guidance reshapes veterinary code protocols
The 2024 RECOVER revision updates veterinary CPR drug use, ventilation, and code tools for dogs and cats.
Drugs
Apomorphine may edge ropinirole in urgent canine decontamination
New comparative data suggest apomorphine may work faster and more reliably than ropinirole in emergency canine emesis.
Drugs
Feline surgery teams rethink temperature control beyond warming blankets
New evidence suggests limb warming or insulation may help reduce heat loss in cats during surgery.
Drugs
Study finds ice packs reduce skin perfusion in dogs
A new AJVR study found a 15-minute ice-pack application reduced skin perfusion in healthy dogs.
Drugs
EVJ podcast puts equine antibiotic stewardship back in focus
A new EVJ podcast spotlights equine antibiotic use as BEVA pushes practices to measure and justify prescribing.
Drugs
Fear Free ties puppy vaccines to early low-stress vet visits
Fear Free says puppy vaccine visits should protect health and build confidence from the start.
Drugs
Tasha McNerney podcast renews focus on pain prevention
A resurfaced podcast spotlights Tasha McNerney’s push for stronger veterinary pain management and technician-led anesthesia education.
Drugs
Equine pain management moves toward structured assessment
Equine pain care is increasingly centered on repeated assessment, multimodal analgesia, and closer monitoring.